These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1045 related articles for article (PubMed ID: 19084097)
21. Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome. Weerakiet S; Sophonsritsuk A; Lertvikool S; Satirapot C; Leelaphiwat S; Jultanmas R J Obstet Gynaecol Res; 2011 Sep; 37(9):1229-37. PubMed ID: 21518135 [TBL] [Abstract][Full Text] [Related]
22. PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene. Johnson NP; Stewart AW; Falkiner J; Farquhar CM; Milsom S; Singh VP; Okonkwo QL; Buckingham KL; Hum Reprod; 2010 Jul; 25(7):1675-83. PubMed ID: 20435692 [TBL] [Abstract][Full Text] [Related]
23. Consensus on infertility treatment related to polycystic ovary syndrome. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Fertil Steril; 2008 Mar; 89(3):505-22. PubMed ID: 18243179 [TBL] [Abstract][Full Text] [Related]
24. Effects of metformin on insulin resistance, androgen concentration, ovulation and pregnancy rates in women with polycystic ovary syndrome following laparoscopic ovarian drilling. Kocak I; Ustün C J Obstet Gynaecol Res; 2006 Jun; 32(3):292-8. PubMed ID: 16764619 [TBL] [Abstract][Full Text] [Related]
25. No more surrogate end-points in randomised trials: the PCOSMIC trial protocol for women with polycystic ovary syndrome using metformin for infertility with clomiphene. Johnson NP Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):141-5. PubMed ID: 16638037 [TBL] [Abstract][Full Text] [Related]
26. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome. Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080 [TBL] [Abstract][Full Text] [Related]
27. The use of metformin as first line treatment in polycystic ovary syndrome. Abbas M; Gannon M Ir Med J; 2008 Feb; 101(2):51-3. PubMed ID: 18450250 [TBL] [Abstract][Full Text] [Related]
28. Pregnancy considerations in women with polycystic ovary syndrome. Legro RS Clin Obstet Gynecol; 2007 Mar; 50(1):295-304. PubMed ID: 17304043 [TBL] [Abstract][Full Text] [Related]
29. Thiazolidinediones for treatment of polycystic ovary syndrome. Stout DL; Fugate SE Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238 [TBL] [Abstract][Full Text] [Related]
30. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765 [TBL] [Abstract][Full Text] [Related]
31. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. Liao L; Tian YJ; Zhao JJ; Xin Y; Xing HY; Dong JJ Chin Med J (Engl); 2011 Mar; 124(5):714-8. PubMed ID: 21518564 [TBL] [Abstract][Full Text] [Related]
32. Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome. Palomba S; Orio F; Falbo A; Russo T; Caterina G; Manguso F; Tolino A; Colao A; Zullo F Clin Endocrinol (Oxf); 2005 Dec; 63(6):631-5. PubMed ID: 16343096 [TBL] [Abstract][Full Text] [Related]
33. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687 [TBL] [Abstract][Full Text] [Related]
34. The effect of metformin plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome. Malkawi HY; Qublan HS Saudi Med J; 2002 Jun; 23(6):663-6. PubMed ID: 12070543 [TBL] [Abstract][Full Text] [Related]
35. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers. Sharma ST; Nestler JE Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155 [TBL] [Abstract][Full Text] [Related]
36. Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Siebert TI; Kruger TF; Steyn DW; Nosarka S Fertil Steril; 2006 Nov; 86(5):1432-7. PubMed ID: 17007847 [TBL] [Abstract][Full Text] [Related]
37. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Nawaz FH; Rizvi J Gynecol Obstet Invest; 2010; 69(3):184-9. PubMed ID: 20029224 [TBL] [Abstract][Full Text] [Related]
38. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response. Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839 [TBL] [Abstract][Full Text] [Related]
39. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Legro RS; Zaino RJ; Demers LM; Kunselman AR; Gnatuk CL; Williams NI; Dodson WC Am J Obstet Gynecol; 2007 Apr; 196(4):402.e1-10; discussion 402.e10-1. PubMed ID: 17403436 [TBL] [Abstract][Full Text] [Related]